|
Name |
Thielavin J
|
Molecular Formula | C29H30O10 | |
IUPAC Name* |
4-[4-(2,4-dihydroxy-3,6-dimethylbenzoyl)oxy-2-methoxy-3,5,6-trimethylbenzoyl]oxy-2-hydroxy-3,6-dimethylbenzoic acid
|
|
SMILES |
CC1=CC(=C(C(=C1C(=O)OC2=C(C(=C(C(=C2C)C)C(=O)OC3=C(C(=C(C(=C3)C)C(=O)O)O)C)OC)C)O)C)O
|
|
InChI |
InChI=1S/C29H30O10/c1-11-9-18(30)15(5)23(31)21(11)28(35)39-25-14(4)13(3)22(26(37-8)17(25)7)29(36)38-19-10-12(2)20(27(33)34)24(32)16(19)6/h9-10,30-32H,1-8H3,(H,33,34)
|
|
InChIKey |
RLLCMRPOSFZYJJ-UHFFFAOYSA-N
|
|
Synonyms |
Thielavin J; 4-[4-(2,4-dihydroxy-3,6-dimethylbenzoyl)oxy-2-methoxy-3,5,6-trimethylbenzoyl]oxy-2-hydroxy-3,6-dimethylbenzoic acid
|
|
CAS | NA | |
PubChem CID | 10875192 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 538.5 | ALogp: | 6.8 |
HBD: | 4 | HBA: | 10 |
Rotatable Bonds: | 8 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 160.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 39 | QED Weighted: | 0.236 |
Caco-2 Permeability: | -5.711 | MDCK Permeability: | 0.00001230 |
Pgp-inhibitor: | 0.367 | Pgp-substrate: | 0.875 |
Human Intestinal Absorption (HIA): | 0.807 | 20% Bioavailability (F20%): | 0.122 |
30% Bioavailability (F30%): | 0.023 |
Blood-Brain-Barrier Penetration (BBB): | 0.001 | Plasma Protein Binding (PPB): | 99.56% |
Volume Distribution (VD): | 0.32 | Fu: | 1.00% |
CYP1A2-inhibitor: | 0.048 | CYP1A2-substrate: | 0.931 |
CYP2C19-inhibitor: | 0.054 | CYP2C19-substrate: | 0.063 |
CYP2C9-inhibitor: | 0.621 | CYP2C9-substrate: | 0.1 |
CYP2D6-inhibitor: | 0.002 | CYP2D6-substrate: | 0.119 |
CYP3A4-inhibitor: | 0.054 | CYP3A4-substrate: | 0.09 |
Clearance (CL): | 2.891 | Half-life (T1/2): | 0.474 |
hERG Blockers: | 0.001 | Human Hepatotoxicity (H-HT): | 0.029 |
Drug-inuced Liver Injury (DILI): | 0.873 | AMES Toxicity: | 0.025 |
Rat Oral Acute Toxicity: | 0.601 | Maximum Recommended Daily Dose: | 0.672 |
Skin Sensitization: | 0.452 | Carcinogencity: | 0.028 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.918 |
Respiratory Toxicity: | 0.261 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002085 | 0.807 | D0WY9N | 0.301 | ||||
ENC000992 | 0.720 | D03RTK | 0.252 | ||||
ENC003651 | 0.702 | D0I3XG | 0.246 | ||||
ENC005301 | 0.697 | D04WJO | 0.240 | ||||
ENC004140 | 0.640 | D0L5FY | 0.231 | ||||
ENC003680 | 0.630 | D0FX2Q | 0.230 | ||||
ENC003695 | 0.587 | D06GCK | 0.230 | ||||
ENC003758 | 0.532 | D05QDC | 0.230 | ||||
ENC004141 | 0.509 | D0Q0PR | 0.228 | ||||
ENC003732 | 0.416 | D0N1FS | 0.224 |